MEDI-570 0.1 MG ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	1

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01127321 (ClinicalTrials.gov)	May 2010	14/4/2010	A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus	A Phase 1, Double-blind, Randomized, Single Ascending Dose Study of the Safety and Tolerability of M ...	Lupus Erythematosus, Systemic	Other: Placebo;Biological: MEDI-570 0.03 MG;Biological: MEDI-570 0.1 MG;Biological: MEDI-570 0.3 MG; ...	MedImmune LLC	AstraZeneca	Terminated	18 Years	N/A	All	44	Phase 1	United States;Canada;Mexico;Peru;South Africa

First Previous1Next Last